Literature DB >> 9885282

Platelet activating factor receptor (PAF-R) is found in a large endosomal compartment in human umbilical vein endothelial cells.

K Ihida1, D Predescu, R P Czekay, G E Palade.   

Abstract

In previous studies, we have localized the platelet activating factor receptor (PAF-R) in situ on the surface of the endothelium in a number of microvascular beds without providing information on its intracellular location. In the present study, we used human umbilical vein cells (HUVECs) as a model to immunolocalize PAF-R by light and electron microscopic procedures. We raised two different polyclonal antibodies against synthetic peptides of the C- and N-terminal of PAF-R and used them for immunolocalization studies. By immunofluorescence, we found that the anti-C-terminal antibody (CPAF-R) stains an extensive intracellular tubular network. By electron microscopy, using a preembedding staining procedure, we detected PAF-R on the surface of the plasmalemma in a staining pattern similar to that described on microvascular endothelia in situ, but at a considerably lower density. Immunogold labeling of thin frozen sections revealed the presence of PAF-R on the plasmalemma, and especially in an extensive network of tubular-vesicular elements and vesicles associated with it. No detectable amounts of PAF-R were found in the endoplasmic reticulum (ER) or in Golgi cisternae. Double immunofluorescence labeling with antibodies for compartment marker proteins and PAF-R revealed that PAF-R localizes in an endosomal compartment. Confocal microscopy showed that PAF-R colocalizes in this compartment together with the transferrin receptor (Tf-R) and the thrombin receptor (TH-R), but it also showed that the colocalization was partial rather than complete. These findings suggest that the endosomal network is either discontinuous or, conversely, that the proteins in its membrane do not have a fully randomized distribution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9885282     DOI: 10.1242/jcs.112.3.285

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  8 in total

1.  Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase.

Authors:  Jinbo Liu; Rui Chen; Gopal K Marathe; Maria Febbraio; Weilin Zou; Thomas M McIntyre
Journal:  Circ Res       Date:  2010-12-23       Impact factor: 17.367

2.  Human TMEM30a promotes uptake of antitumor and bioactive choline phospholipids into mammalian cells.

Authors:  Rui Chen; Erin Brady; Thomas M McIntyre
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

3.  Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells.

Authors:  Eugen Brailoiu; Christine L Barlow; Servio H Ramirez; Mary E Abood; G Cristina Brailoiu
Journal:  Neuroscience       Date:  2018-03-06       Impact factor: 3.590

4.  Prolonged hypoxia modulates platelet activating factor receptor-mediated responses by fetal ovine pulmonary vascular smooth muscle cells.

Authors:  Lissette S Renteria; J Usha Raj; Basil O Ibe
Journal:  Mol Genet Metab       Date:  2010-08-10       Impact factor: 4.797

5.  PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis.

Authors:  B Bussolati; L Biancone; P Cassoni; S Russo; M Rola-Pleszczynski; G Montrucchio; G Camussi
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

Review 6.  Lipid signaling in neural plasticity, brain repair, and neuroprotection.

Authors:  Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

7.  Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction.

Authors:  Sanda Predescu; Ivana Knezevic; Cristina Bardita; Radu Florin Neamu; Viktor Brovcovych; Dan Predescu
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

8.  Impaired caveolae function and upregulation of alternative endocytic pathways induced by experimental modulation of intersectin-1s expression in mouse lung endothelium.

Authors:  Dan N Predescu; Radu Neamu; Cristina Bardita; Minhua Wang; Sanda A Predescu
Journal:  Biochem Res Int       Date:  2012-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.